(Q60716878)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15721356%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

VSV replication in neurons is inhibited by type I IFN at multiple stages of infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15721356%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15721356%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Mark D Trottier

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15721356%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Beth M Palian

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15721356%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

language of work or name

English

0 references

publication date

1 March 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15721356%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

0 references

333

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15721356%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15721356%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

215-225

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15721356%20AND%20SRC:MED&resulttype=core&format=json

Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

The cross-species antiviral activities of different IFN-tau subtypes on bovine, murine, and human cells: contradictory evidence for therapeutic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Localized catecholamine storage associated with granules in murine neuroblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Constitutive expression of (2'-5') oligo A synthetase confers resistance to picornavirus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

In HIV-1-infected patients, plasma levels of HIV-1 RNA are inversely correlated with IFN-alpha responsiveness of whole-blood cultures to sendai virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

PKR is not required for interferon-gamma inhibition of VSV replication in neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Comparative study of the efficacy of different forms of interferon therapy in the treatment of mice challenged intranassaly with vesicular stomatitis virus (VSV).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

PKR protection against intranasal vesicular stomatitis virus infection is mouse strain dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Biological activities of synthetic peptides of the sequence of human interferon-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Role of nucleoporin induction in releasing an mRNA nuclear export block

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

An antiviral soluble form of the LDL receptor induced by interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Complex nuclear localization signals in the matrix protein of vesicular stomatitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Efficacy of Exogenous Interferon Treatment Initiated After Onset of Multiplication of Vesicular Stomatitis Virus in the Brains of Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Microinjection of Interferon and 2′,5′-Oligoadenylate into Mouse L Cells and Their Effects on Virus Growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

The target reaction in the antiviral action of mouse interferon against vesicular stomatitis virus multiplication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Effect of deficiency of the double-stranded RNA-dependent protein kinase, PKR, on antiviral resistance in the presence or absence of ribonuclease L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Interferon-gamma induced type I nitric oxide synthase activity inhibits viral replication in neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Mechanisms of Cytokine-Mediated Inhibition of Viral Replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Recombinant vesicular stomatitis viruses from DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Effect of interferon treatment on vesicular stomatitis virus (VSV): release of unusual particles with low infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Interferon treatment inhibits glycosylation of a viral protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Interferon-treated cells release vesicular stomatitis virus particles lacking glycoprotein spikes: correlation with biochemical data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Interferon Action III. The Rate of Primary Transcription of Vesicular Stomatitis Virus is Inhibited by Interferon Action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Functional role of type I and type II interferons in antiviral defense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Effect of recombinant murine interferon-beta on the replication of murine cytomegalovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Regulation of the antiviral and anticellular activities of interferon by exogenous double-stranded RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

INFLUENCE OF HOST FACTORS ON NEUROINVASIVENESS OF VESICULAR STOMATITIS VIRUS : I. EFFECT OF AGE ON THE INVASION OF THE BRAIN BY VIRUS INSTILLED IN THE NOSE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Mechanism of interferon action: Human leukocyte and immune interferons regulate the expression of different genes and induce different antiviral states in human amnion U cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

In vitro differentiation of a mouse neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Anti-HIV-1 activity of recombinant and hybrid species of interferon-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Effect of Interferon on Transcription and Translation of Vesicular Stomatitis Virus in Human and Simian Cell Cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Oromucosal interferon therapy: marked antiviral and antitumor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.009

10.1016/J.VIROL.2005.01.009

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15721356%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference